KROS - Keros Therapeutics  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KROS is currently covered by 9 analysts with an average price target of $32.1. This is a potential upside of $16.44 (104.98%) from yesterday's end of day stock price of $15.66.

Keros Therapeutics 's activity chart (see below) currently has 33 price targets and 57 ratings on display. The stock rating distribution of KROS is 87.5% BUY and 12.5% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 30.71% with an average time for these price targets to be met of 47.9 days.

Highest price target for KROS is $26, Lowest price target is $15, average price target is $23.33.

Most recent stock forecast was given by GREG HARRISON from SCOTIABANK on 12-May-2025. First documented stock forecast 04-May-2020.

Currently out of the existing stock ratings of KROS, 28 are a BUY (87.5%), 4 are a HOLD (12.5%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$26

$10.34 (66.03%)

$41

4 months 1 days ago
(12-May-2025)

1/6 (16.67%)

$12.26 (89.23%)

215

Buy

$25

$9.34 (59.64%)

$40

4 months 5 days ago
(08-May-2025)

1/14 (7.14%)

$10.98 (78.32%)

113

Buy

$25

$9.34 (59.64%)

$43

5 months 4 days ago
(09-Apr-2025)

0/6 (0%)

$14.67 (142.01%)

Buy

$26

$10.34 (66.03%)

$111

6 months 17 days ago
(27-Feb-2025)

1/3 (33.33%)

$15.06 (137.66%)

74

Buy

$15

$-0.66 (-4.21%)

$105

7 months 27 days ago
(17-Jan-2025)

6/12 (50%)

$4.14 (38.12%)

59

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is KROS (Keros Therapeutics ) average time for price targets to be met?

On average it took 47.9 days on average for the stock forecasts to be realized with a an average price target met ratio 30.71

Which analyst has the current highest performing score on KROS (Keros Therapeutics ) with a proven track record?

JOSEPH CATANZARO

Which analyst has the most public recommendations on KROS (Keros Therapeutics )?

Joseph Catanzaro works at PIPER SANDLER and has 9 price targets and 7 ratings on KROS

Which analyst is the currently most bullish on KROS (Keros Therapeutics )?

Thomas Smith with highest potential upside - $31.36

Which analyst is the currently most reserved on KROS (Keros Therapeutics )?

Joseph Catanzaro with lowest potential downside - -$0.66

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?